Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: A novel bridge between oxidative stress and preeclampsia

Placenta

Volumn 34, Issue 12, 2013, Pages 1177-1182

  Huang, Q T ^a   Zhang, M ^a   Zhong, M ^a   Yu, Y H ^a   Liang, W Z ^a   Hang, L L ^a   Gao, Y F ^a   Huang, L P ^a   Wang, Z J ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Advanced glycation end products; Soluble fms like tyrosine kinase 1; Trophoblast

Indexed keywords

ADVANCED GLYCATION END PRODUCT; APOCYNIN; IMMUNOGLOBULIN G; MESSENGER RNA; PLACENTAL GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; SOLUBLE FMS LIKE TYROSINE KINASE 1; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL LINE; ENZYME RELEASE; GENE EXPRESSION; OXIDATIVE STRESS; PREECLAMPSIA; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TROPHOBLAST;

ADVANCED GLYCATION END PRODUCTS; SOLUBLE FMS-LIKE TYROSINE KINASE 1; TROPHOBLAST;

ACETOPHENONES; CELL LINE; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOGLOBULIN G; MOLECULAR TARGETED THERAPY; NADPH OXIDASE; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SERUM ALBUMIN, BOVINE; TROPHOBLASTS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84888315117     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2013.09.017     Document Type: Article

References (40)

1. E.A. Steegers, P. von Dadelszen, J.J. Duvekot, and R. Pijnenborg Pre-eclampsia Lancet 376 9741 2010 Aug 21 631 644
2. T. Oreshkova, R. Dimitrov, and M. Mourdjeva A cross-talk of decidual stromal cells, trophoblast, and immune cells: a prerequisite for the success of pregnancy Am J Reprod Immunol 68 5 2012 Nov 366 373
3. P.L. Pfeffer, and D.J. Pearton Trophoblast development Reproduction 143 3 2012 Mar 231 246
4. A. Leaños-Miranda, I. Campos-Galicia, K.L. Ramírez- Valenzuela, Z.L. Chinolla-Arellano, and I. Isordia-Salas Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia Hypertension 61 5 2013 May 1118 1125
5. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, and K.F. Yu Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 7 2004 Feb 12 672 683
6. S.A. Karumanchi, and Y. Bdolah Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question Endocrinology 145 11 2004 Nov 4835 4837
7. G.C. Smith, J.A. Crossley, D.A. Aitken, N. Jenkins, F. Lyall, and A.D. Cameron Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth Obstet Gynecol 109 6 2007 Jun 1316 1324
8. C. Signore, J.L. Mills, C. Qian, K. Yu, C. Lam, and F.H. Epstein Circulating angiogenic factors and placental abruption Obstet Gynecol 108 2 2006 Aug 338 344
9. C.E. Kleinrouweler, M.M. Wiegerinck, C. Ris-Stalpers, P.M. Bossuyt, J.A. van der Post, P. von Dadelszen EBM CONNECT Collaboration Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis BJOG 119 7 2012 Jun 778 787
10. S. Masoura, I.A. Kalogiannidis, G. Gitas, A. Goutsioulis, E. Koiou, and A. Athanasiadis Biomarkers in pre-eclampsia: a novel approach to early detection of the disease J Obstet Gynaecol 32 7 2012 Oct 609 616
11. E.M. George, and J.P. Granger Mechanisms and potential therapies for preeclampsia Curr Hypertens Rep 13 4 2011 Aug 269 275
12. S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, and S. Mondal Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 5 2003 Mar 649 658
13. G. Vistoli, D. De Maddis, A. Cipak, N. Zarkovic, M. Carini, and G. Aldini Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation Free Radic Res 47 Suppl. 1 2013 Aug 3 27
14. H. Vlassara, and G.E. Striker AGE restriction in diabetes mellitus: a paradigm shift Nat Rev Endocrinol 7 9 2011 May 24 526 539
15. K.H. Gaens, C.D. Stehouwer, and C.G. Schalkwijk Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity Curr Opin Lipidol 24 1 2013 Feb 4 11
16. C. Piperi, C. Adamopoulos, G. Dalagiorgou, E. Diamanti-Kandarakis, and A.G. Papavassiliou Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases J Clin Endocrinol Metab 97 7 2012 Jul 2231 2242
17. K.A. Toulis, D.G. Goulis, G. Mintziori, E. Kintiraki, E. Eukarpidis, and S.A. Mouratoglou Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome Hum Reprod Update 17 6 2011 Nov-Dec 741 760
18. C. Chekir, M. Nakatsuka, S. Noguchi, H. Konishi, Y. Kamada, and A. Sasaki Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress Placenta 27 2-3 2006 Feb-Mar 225 233
19. E.A. Oliver, C.S. Buhimschi, A.T. Dulay, M.A. Baumbusch, S.S. Abdel-Razeq, and S.Y. Lee Activation of the receptor for advanced glycation end products system in women with severe preeclampsia J Clin Endocrinol Metab 96 3 2011 Mar 689 698
20. L. Guedes-Martins, L. Matos, A. Soares, E. Silva, and H. Almeida AGEs, contributors to placental bed vascular changes leading to preeclampsia Free Radic Res 47 Suppl. 1 2013 Aug 70 80
21. L. Shi, X. Yu, H. Yang, and X. Wu Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways PLoS One 8 6 2013 Jun 12 e66781
22. B.E. Harcourt, K.C. Sourris, M.T. Coughlan, K.Z. Walker, S.L. Dougherty, and S. Andrikopoulos Targeted reduction of advanced glycation improves renal function in obesity Kidney Int 80 2 2011 Jul 190 198
23. M. Jinno, M. Takeuchi, A. Watanabe, K. Teruya, J. Hirohama, and N. Eguchi Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology Hum Reprod 26 3 2011 Mar 604 610
24. Z.J. Guo, H.X. Niu, F.F. Hou, L. Zhang, N. Fu, and R. Nagai Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway Antioxid Redox Signal 10 10 2008 Oct 1699 1712
25. H. Konishi, M. Nakatsuka, C. Chekir, S. Noguchi, Y. Kamada, and A. Sasaki Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts Hum Reprod 19 9 2004 Sep 2156 2162
26. Y. Khong, and I. Brosens Defective deep placentation Best Pract Res Clin Obstet Gynaecol 25 3 2011 Jun 301 311
27. D. Farley, M.E. Tejero, A.G. Comuzzie, P.B. Higgins, L. Cox, and S.L. Werner Feto-placental adaptations to maternal obesity in the baboon Placenta 30 9 2009 Sep 752 760
28. Z. Yamada, M. Kitagawa, T. Takemura, and K. Hirokawa Effect of maternal age on incidences of apoptotic and proliferative cells in trophoblasts of full-term human placenta Mol Hum Reprod 7 12 2001 Dec 1179 1185
29. C. Liang, K. DeCourcy, and M.R. Prater High-saturated-fat diet induces gestational diabetes and placental vasculopathy in C57BL/6 mice Metabolism 59 7 2010 Jul 943 950
30. S. Palomba, T. Russo, A. Falbo, A. Di Cello, G. Amendola, and R. Mazza Decidual endovascular trophoblast invasion in women with polycystic ovary syndrome: an experimental case-control study J Clin Endocrinol Metab 97 7 2012 Jul 2441 2449
31. S. Yamagishi, K. Nakamura, T. Matsui, Y. Noda, and T. Imaizumi Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication Curr Pharm Des 14 5 2008 487 495
32. Q. Wei, X. Ren, Y. Jiang, H. Jin, N. Liu, and J. Li Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress BMC Cardiovasc Disord 13 2013 Mar 5 13
33. N. Mahajan, and V. Dhawan Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases Int J Cardiol 2013 May 27 10.1016/j.ijcard.2013.05.013 pii: S0167-5273(13)00922-4. [Epub ahead of print]
34. L. Feng, M.M. Zhu, M.H. Zhang, R.S. Wang, X.B. Tan, and J. Song Protection of glycyrrhizic acid against AGEs-induced endothelial dysfunction through inhibiting RAGE/NF-κB pathway activation in human umbilical vein endothelial cells J Ethnopharmacol 148 1 2013 Jun 21 27 36
35. V. Thallas-Bonke, S.R. Thorpe, M.T. Coughlan, K. Fukami, F.Y. Yap, and K.C. Sourris Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway Diabetes 57 2 2008 Feb 460 469
36. S.R. Murphy, B.B. LaMarca, M. Parrish, K. Cockrell, and J.P. Granger Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α Am J Physiol Regul Integr Comp Physiol 304 2 2013 Jan 15 R130 R135
37. E. Laresgoiti-Servitje, and N. Gomez-Lopez The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms Biol Reprod 87 2 2012 Aug 23 36
38. Y. Liu, Y. Ma, R. Wang, C. Xia, R. Zhang, and K. Lian Advanced glycation end products accelerate ischemia/reperfusion injury through receptor of advanced end product/nitrative thioredoxin inactivation in cardiac microvascular endothelial cells Antioxid Redox Signal 15 7 2011 Oct 1 1769 1778
39. C.J. Lockwood, S.J. Huang, G. Krikun, R. Caze, M. Rahman, and L.F. Buchwalder Decidual hemostasis, inflammation, and angiogenesis in pre-eclampsia Semin Thromb Hemost 37 2 2011 Mar 158 164
40. J.J. Jung, A. Tiwari, S.M. Inamdar, C.P. Thomas, A. Goel, and A. Choudhury Secretion of soluble vascular endothelial growth factor receptor 1 (sVEGFR1/sFlt1) requires Arf1, Arf6, and Rab11 GTPases PLoS One 7 9 2012 e44572